The influence of cognitive impairment on driving performance in multiple sclerosis

Neurology
Maria T SchultheisJohn DeLuca

Abstract

To examine the influence of impaired cognitive processing on measures of driving skills in persons with MS. Twenty-eight subjects with documented MS were divided into two groups-with [MS(+), n = 13] and without [MS(-), n = 15] cognitive impairment-based on neuropsychological performance. Healthy control (HC) subjects (n = 17) matched on age and driving experience were also studied. Driving-related skills were compared between the groups based on performance on two computerized driving tests: the Useful Field of Vision (UFOV) and the Neurocognitive Driving Test (NDT). The MS(+) group performed significantly worse than both the MS(-) and HC groups in the latency to perform several driving-specific functions on the NDT, but no overall group differences were observed in actual errors on the NDT. On the UFOV, when compared to MS(-) and HC subjects, the MS(+) group demonstrated poorer performance on two of the three subtests. Additionally, a significantly higher percentage of MS(+) individuals were rated within the high risk (probability of crash involvement) category, relative to the MS(-) and HC groups. Cognitive impairment can negatively affect driving-related skills in persons with MS and should be considered in the determination...Continue Reading

Citations

May 18, 2006·Archives of Clinical Neuropsychology : the Official Journal of the National Academy of Neuropsychologists·Jerri D EdwardsKarlene K Ball
Sep 14, 2007·Archives of Clinical Neuropsychology : the Official Journal of the National Academy of Neuropsychologists·Amanda O'BrienJohn DeLuca
Jan 9, 2009·Journal of the International Neuropsychological Society : JINS·Christopher ChristodoulouLauren B Krupp
Apr 28, 2007·Assistive Technology : the Official Journal of RESNA·Maria T SchultheisScott R Millis
Aug 15, 2008·Multiple Sclerosis : Clinical and Laboratory Research·R S PrakashA F Kramer
Mar 13, 2014·Archives of Physical Medicine and Rehabilitation·Meghan BeierGeorge H Kraft
Dec 2, 2014·Current Physical Medicine and Rehabilitation Reports·Maria T Schultheis, Elizabeth Whipple
Jun 15, 2014·Archives of Physical Medicine and Rehabilitation·Meaghan DehningNatalie L Denburg
Feb 28, 2002·The Journal of Head Trauma Rehabilitation·Jean LengenfelderJohn DeLuca
May 17, 2005·Physical Medicine and Rehabilitation Clinics of North America·Mary Pepping, Dawn M Ehde
Feb 2, 2006·Journal of Clinical and Experimental Neuropsychology·Thomas D MarcotteUNKNOWN HNRC Group
Jul 9, 2008·Journal of Clinical and Experimental Neuropsychology·Kelly A RyanRobert Lisak
Aug 21, 2013·Journal of Clinical and Experimental Neuropsychology·Yael GoveroverJohn DeLuca
Jul 1, 2012·International Journal of MS Care·Abiodun Emmanuel AkinwuntanJerry Wachtel
Oct 15, 2010·The International Journal of Neuroscience·Maria MelansonMichael Namaka
Feb 18, 2016·CNS Drugs·Shumita RoyBianca Weinstock-Guttman
Sep 18, 2007·Expert Review of Neurotherapeutics·Adrienne R Boissy, Jeffrey A Cohen
Mar 8, 2011·Expert Review of Neurotherapeutics·Peter A Arnett, Lauren B Strober
Mar 8, 2011·Expert Review of Neurotherapeutics·Massimiliano CalabresePaolo Gallo
Mar 5, 2014·Disability and Rehabilitation·Ornella ArgentoUgo Nocentini
May 21, 2013·Disability and Rehabilitation·Hannes DevosPeter Feys
Oct 1, 2012·Multiple Sclerosis and Related Disorders·Helen LapshinAnthony Feinstein
Mar 29, 2011·Neurologic Clinics·Laura J Julian
May 25, 2010·Physical Medicine and Rehabilitation Clinics of North America·Michelle SternKevin Sperber
Mar 20, 2010·Archives of Physical Medicine and Rehabilitation·Maria T SchultheisScott R Millis
Jun 2, 2009·Archives of Physical Medicine and Rehabilitation·Maria T SchultheisJocelyn Ang
Mar 5, 2004·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Christian WeinPeter Schauder
Sep 2, 2008·Archives of Physical Medicine and Rehabilitation·Thomas D MarcotteJody Corey-Bloom
Nov 29, 2015·Neurologic Clinics·Abdorreza Naser MoghadasiMohammad Ali Sahraian
Apr 22, 2006·Journal of the Neurological Sciences·Christopher ChristodoulouLauren B Krupp
Nov 25, 2004·Physical Medicine and Rehabilitation Clinics of North America·Michelle Stern
Feb 18, 2010·Archives of Physical Medicine and Rehabilitation·Yael GoveroverJohn DeLuca
Feb 18, 2010·Archives of Physical Medicine and Rehabilitation·Maria T SchultheisMark E Wilkinson
Apr 14, 2016·Journal of Neurology·Brian M SandroffJohn DeLuca
Jan 27, 2015·European Archives of Psychiatry and Clinical Neuroscience·Georg Adler, Yvonne Lembach
May 16, 2015·Journal français d'ophtalmologie·C MarksC Moroni
Jan 1, 2014·Multiple Sclerosis and Related Disorders·Simon J HickmanIrene Gottlob
May 21, 2014·Journal of the Neurological Sciences·Naghmeh MokhberMahmoud Reza Azarpazhooh
Jan 1, 2011·OTJR : Occupation, Participation and Health·Gerald T VoelbelJohn Deluca
Jan 6, 2010·Research in Developmental Disabilities·Sara Rosenblum, Patrice L Tamar Weiss
Oct 27, 2016·Archives of Physical Medicine and Rehabilitation·Yael GoveroverJohn DeLuca
Jul 5, 2012·Multiple Sclerosis : Clinical and Laboratory Research·Abiodun Emmanuel AkinwuntanMitzi Joi Williams

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.